A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene.

Posterior cortical atrophy is a dementia syndrome with symptoms of cortical visual dysfunction, associated with amyloid plaques and neurofibrillary tangles predominantly affecting visual association cortex. Most patients diagnosed with posterior cortical atrophy will finally develop a typical Alzhei...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Emilia J Sitek, Ewa Narożańska, Beata Pepłońska, Sławomir Filipek, Anna Barczak, Maria Styczyńska, Krzysztof Mlynarczyk, Bogna Brockhuis, Erik Portelius, Dorota Religa, Maria Barcikowska, Jarosław Sławek, Cezary Żekanowski
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/97b85122553d461a86a5788abdf22207
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:97b85122553d461a86a5788abdf22207
record_format dspace
spelling oai:doaj.org-article:97b85122553d461a86a5788abdf222072021-11-18T07:49:36ZA patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene.1932-620310.1371/journal.pone.0061074https://doaj.org/article/97b85122553d461a86a5788abdf222072013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23593396/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Posterior cortical atrophy is a dementia syndrome with symptoms of cortical visual dysfunction, associated with amyloid plaques and neurofibrillary tangles predominantly affecting visual association cortex. Most patients diagnosed with posterior cortical atrophy will finally develop a typical Alzheimer's disease. However, there are a variety of neuropathological processes, which could lead towards a clinical presentation of posterior cortical atrophy. Mutations in the presenilin 1 gene, affecting the function of γ-secretase, are the most common genetic cause of familial, early-onset Alzheimer's disease. Here we present a patient with a clinical diagnosis of posterior cortical atrophy who harbors a novel Presenilin 1 mutation (I211M). In silico analysis predicts that the mutation could influence the interaction between presenilin 1 and presenilin1 enhancer-2 protein, a protein partner within the γ-secretase complex. These findings along with published literature support the inclusion of posterior cortical atrophy on the Alzheimer's disease spectrum.Emilia J SitekEwa NarożańskaBeata PepłońskaSławomir FilipekAnna BarczakMaria StyczyńskaKrzysztof MlynarczykBogna BrockhuisErik PorteliusDorota ReligaMaria BarcikowskaJarosław SławekCezary ŻekanowskiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 4, p e61074 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Emilia J Sitek
Ewa Narożańska
Beata Pepłońska
Sławomir Filipek
Anna Barczak
Maria Styczyńska
Krzysztof Mlynarczyk
Bogna Brockhuis
Erik Portelius
Dorota Religa
Maria Barcikowska
Jarosław Sławek
Cezary Żekanowski
A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene.
description Posterior cortical atrophy is a dementia syndrome with symptoms of cortical visual dysfunction, associated with amyloid plaques and neurofibrillary tangles predominantly affecting visual association cortex. Most patients diagnosed with posterior cortical atrophy will finally develop a typical Alzheimer's disease. However, there are a variety of neuropathological processes, which could lead towards a clinical presentation of posterior cortical atrophy. Mutations in the presenilin 1 gene, affecting the function of γ-secretase, are the most common genetic cause of familial, early-onset Alzheimer's disease. Here we present a patient with a clinical diagnosis of posterior cortical atrophy who harbors a novel Presenilin 1 mutation (I211M). In silico analysis predicts that the mutation could influence the interaction between presenilin 1 and presenilin1 enhancer-2 protein, a protein partner within the γ-secretase complex. These findings along with published literature support the inclusion of posterior cortical atrophy on the Alzheimer's disease spectrum.
format article
author Emilia J Sitek
Ewa Narożańska
Beata Pepłońska
Sławomir Filipek
Anna Barczak
Maria Styczyńska
Krzysztof Mlynarczyk
Bogna Brockhuis
Erik Portelius
Dorota Religa
Maria Barcikowska
Jarosław Sławek
Cezary Żekanowski
author_facet Emilia J Sitek
Ewa Narożańska
Beata Pepłońska
Sławomir Filipek
Anna Barczak
Maria Styczyńska
Krzysztof Mlynarczyk
Bogna Brockhuis
Erik Portelius
Dorota Religa
Maria Barcikowska
Jarosław Sławek
Cezary Żekanowski
author_sort Emilia J Sitek
title A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene.
title_short A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene.
title_full A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene.
title_fullStr A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene.
title_full_unstemmed A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene.
title_sort patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/97b85122553d461a86a5788abdf22207
work_keys_str_mv AT emiliajsitek apatientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT ewanarozanska apatientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT beatapepłonska apatientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT sławomirfilipek apatientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT annabarczak apatientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT mariastyczynska apatientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT krzysztofmlynarczyk apatientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT bognabrockhuis apatientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT erikportelius apatientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT dorotareliga apatientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT mariabarcikowska apatientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT jarosławsławek apatientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT cezaryzekanowski apatientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT emiliajsitek patientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT ewanarozanska patientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT beatapepłonska patientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT sławomirfilipek patientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT annabarczak patientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT mariastyczynska patientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT krzysztofmlynarczyk patientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT bognabrockhuis patientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT erikportelius patientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT dorotareliga patientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT mariabarcikowska patientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT jarosławsławek patientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
AT cezaryzekanowski patientwithposteriorcorticalatrophypossessesanovelmutationinthepresenilin1gene
_version_ 1718422927421997056